Team Science Award

The purpose of the Team Science Award is to stimulate the development of high-quality, multi-investigator (minimum of three) program project grants that will develop into extramurally-funded grant awards. 

Purpose and Overview | Eligibility | Evaluation | Timelines

Team Science Award

Applications are not being accepted at this time.

Purpose and Overview

Projects with translational potential are encouraged, but not mandatory. Inter-programmatic and inter-institutional teams are highly encouraged. MUSC Hollings Cancer Center leadership anticipates distributing awards up to $150,000 per year for up to two years. Year 2 is contingent on the submission of an annual progress report (month 11) and a presentation to Hollings leadership showing satisfactory progress toward project goals. The presentation will be scheduled by a member of the Hollings administration team.

Additional progress reports are expected upon project completion and annually for five years following the conclusion of the award. Any no-cost extensions will require prior approval. Sources of funding for the award include the Hollings Cancer Center Support Grant (P30 CA138313), fundraising from the LOWVELO bike ride, and other Hollings philanthropy/foundation accounts.

PIs are expected to obtain regulatory approvals [e.g., IACUC and IRB] within three months of award decision. Please note that funding cannot be released until all applicable human subject and animal protocols have been approved and copies have been sent to Brett Bechtol  (


  • Proposed research must be cancer-relevant.
  • Applications must propose a team comprising at least three investigators/project leaders and projects supporting a unifying scientific theme.
  • Must be an MUSC faculty member. 
  • Research must take place, and expenditures incurred, at MUSC.
  • The overall PI(s) must have a strong track record of peer-reviewed funding (active R01 grant or equivalent).
  • All awarded PIs and project leads are encouraged to participate as a registered rider in the annual LOWVELO bike ride event.


Each full application will be assigned to internal and external reviewers who have substantial expertise in cancer research and in reviewing programmatic, center-level grants.

Review criteria include:

  • Standard NIH criteria (significance, innovation, approach, and investigative team).         
  • Likelihood that preliminary results will lead to external, peer-reviewed funding.
  • Program project synergy (synergy, leadership, strength of the investigators, productivity, and potential impact of the proposed research).
  • Participation in Hollings Cancer Center programs (e.g., attend program meetings, participate in grant review panels, participate in annual research symposia, etc.).    
  • The Future Funding Plan (see instructions) must describe how the funds will provide data that is critical to future extramural grant application(s).
  • When appropriate, describe the likelihood that research will ultimately produce intellectual property, such as patents.

Applicants are strongly encouraged to consult a biostatistician when developing the research design and methods of their proposalsPlease use the Biostatistics Resource Request Form to submit your biostatistics requests.


Letter of Intent to submit is due Monday, August 15, 2022, by midnight.  This notification is mandatory to moving forward in the application process and should include preliminary titles for each of the projects and cores, names of Project Leads, Core Directors, and other collaborators, including academic titles and departments.  To begin the application process by submitting a letter of intent, visit the application portal found at the top of your screen.

A formal presentation of the overall program and individual projects' aims, goals, and preliminary data for each application is expected, which should include a 45-minute presentation and a 45-minute discussion to emphasize the integration and history of prior/present collaborative nature of the program. This presentation will be scheduled accordingly for September 2022 for each application. Details will be distributed after submission of the letter of intent to submit. The presentation will be for select Hollings senior investigators who have expertise in PPG or multi-PI NIH grants to provide instant feedback and critiques prior to final submission.

Full applications are due on Monday, December 5, 2022, by midnight. Please note that you will not be able to submit a full application without having completed the letter of intent or formal presentation. Notifications of award will be made after peer review in late January. The start date is expected to be March 1, 2023, and will be dependent on the status of human and animal studies protocol approvals. Applicants receiving a score just outside the funding range will be notified, with the possibility of resubmitting their application for a subsequent RFA cycle.